Biomerieux 69 Marcy (BMXMF) 153.0001 $BMXMF Str
Post# of 273254
Posted On: 09/22/2016 9:09:41 AM
Biomerieux 69 Marcy (BMXMF) 153.0001 $BMXMF
Strategies in the Global Immunoprotein Diagnostic Testing Market 2015 - Includes Stategic Profiles of Leading Suppliers
M2 - Thu Aug 13, 10:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rw5f5m/2015_strategies) has announced the addition of the "2015 Strategies in the Global Immunoprotein Diagnostic Testing Market" report to their offering. This new 297-page report contains 72 tables and provides analysis of the global immunoprotein diagnostic market, including: - emerging tests - technologies - instrumentation - sales forecasts by country - market shares - strategic profiles of leading suppliers Companies Mentioned: - Abbott Laboratories - AdnaGen - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - Dako - DiaSorin - Eiken - Fujirebio - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/rw...strategies About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
ABT: 41.93 (+0.01), DHR: 77.45 (+0.73)
2015-2019 Global Transfusion Diagnostic Testing Market: US, Europe, Japan--Strategic Profiles of Leading Suppliers, Country Volume and Sales Forecasts
PR Newswire Europe - Mon Aug 10, 11:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pdhqcr/20152019_global [http://www.researchandmarkets.com/research/pdhqcr/20152019_global]) has announced the addition of the "2015-2019 Global Transfusion Diagnostic Testing Market: US, Europe, Japan--Strategic Profiles of Leading Suppliers, Country Volume and Sales Forecasts" [http://www.researchandmarkets.com/research/pdhqcr/20152019_global] report to their offering.
DHR: 77.45 (+0.73)
2015-2019 Global Transfusion Diagnostic Testing Market - Presents Analyses of Leading Current and Emerging Suppliers
M2 - Mon Aug 10, 9:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z4c75f/20152019_global) has announced the addition of the "2015-2019 Global Transfusion Diagnostic Testing Market: US, Europe, Japan--Strategic Profiles of Leading Suppliers, Country Volume and Sales Forecasts" report to their offering. 2015-2019 Global Transfusion Diagnostic Testing Market: US, Europe, Japan--Strategic Profiles of Leading Suppliers, Country Volume and Sales Forecasts This report provides a worldwide overview of the Transfusion Diagnostic Testing market, including estimates of facilities performing blood banking tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country. The report also presents analyses of leading current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Table of Contents 1. Worldwide Business Environment 2. Worldwide Market Structure 3. Worldwide Market Size and Growth 4. Competitive Assessments: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Gen-Probe - Grifols - Immucor - Ortho-Clinical Diagnostics - Proteome Sciences - Roche - Siemens - Tecan List of Tables Worldwide, All Market Segments, Facilities Performing Blood Bank Tests By Country Worldwide, All Market Segments, Blood Typing and Grouping Test Volume Forecast By Country Worldwide, All Market Segments, Infectious Disease Screening Test Volume Forecast By Country Worldwide, All Market Segments, Blood Typing and Grouping Reagent Market Forecast By Country Worldwide, All Market Segments, Infectious Disease Screening Reagent Market Forecast By Country For more information visit http://www.researchandmarkets.com/research/z4...019_global
DHR: 77.45 (+0.73)
2015 New Frontiers in US Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape
M2 - Thu Aug 06, 9:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4h3942/2015_new) has announced the addition of the "2015 New Frontiers in US Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape" report to their offering. 2015 New Frontiers in US Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape is a new study of the major business opportunities emerging in the US clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the US market; provides estimates of the specimen, test and sales volumes, as well as major suppliers' sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years. The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables. The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators. Companies Mentioned - Abbott Laboratories - AdnaGen/Alere - Agilent Technologies - Bayer Healthcare - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - DiaSorin - Eiken - Fujirebio - Grifols - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Quest Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/4h3942/2015_new
ABT: 41.93 (+0.01), A: 46.04 (+0.33), DGX: 84.86 (+1.76), DHR: 77.45 (+0.73)
2015 US Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test
M2 - Thu Aug 06, 9:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jf2lnb/2015_us_sales_and) has announced the addition of the "2015 US Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test" report to their offering. This unique report provides US sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher List of Tables - U.S.A., Major Suppliers of Blood Typing and Grouping Reagents Sales and Market Shares - U.S.A., HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier - U.S.A., Hepatitis Blood Screening Market, Reagents Sales by Major Supplier - U.S.A., Hepatitis C Blood Screening Market, Reagent Sales by Major Supplier - U.S.A., HIV/Hepatitis C NAT Market, Reagent Sales by Major Supplier - U.S.A., West Nile Virus NAT Market, Reagent Sales by Major Supplier - U.S.A., CMV Blood Screening Market, Reagent Sales by Major Supplier - U.S.A., Syphilis Blood Screening Market, Reagent Sales by Major Supplier Contains 87 pages and 8 tables For more information visit http://www.researchandmarkets.com/research/jf..._sales_and
DHR: 77.45 (+0.73), HOLX: 38.53 (+0.29)
Global Infectious Disease Molecular Diagnostics Market 2015: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape
M2 - Wed Jul 29, 6:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kkvb5t/2015_global) has announced the addition of the "2015 Global Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape" report to their offering. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry.The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. This new seven-country study contains 775 pages, 73 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. Worldwide Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment. - Five-year test volume and sales projections by country. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country. Product/Technology Review - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Pharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forenciscs/LabCorp - DecodeGenetics - Diadexus - Eiken - Elitech Group - Enzo - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/kk...015_global
MYGN: 20.75 (-0.01), A: 46.04 (+0.33), CPHD: 52.53 (+0.04), DHR: 77.45 (+0.73), HOLX: 38.53 (+0.29)
US Nucleic Acid Testing/NAT Market 2015-2019: Sales and Market Shares of Major Suppliers
M2 - Mon Jul 20, 9:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/brtn3w/20152019_us) has announced the addition of the "2015-2019 US Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom For more information visit http://www.researchandmarkets.com/research/br...0152019_us
SQNM: 2.39 (-0.01), MYGN: 20.75 (-0.01), A: 46.04 (+0.33), CPHD: 52.53 (+0.04), DHR: 77.45 (+0.73), HOLX: 38.53 (+0.29)
US Molecular Diagnostics Market 2015-2019 - Sales and Market Shares of Major Suppliers
M2 - Mon Jul 20, 9:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9x3trk/20152019_us) has announced the addition of the "2015-2019 US Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Eiken - Elitech Group - Enzo - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/9x...0152019_us
SQNM: 2.39 (-0.01), MYGN: 20.75 (-0.01), A: 46.04 (+0.33), CPHD: 52.53 (+0.04), DHR: 77.45 (+0.73), HOLX: 38.53 (+0.29)
2015-2019 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets
M2 - Fri Jul 10, 10:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kx789r/20152019_u_s) has announced the addition of the "2015-2019 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies" report to their offering. Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. Report Highlights - Market shares of leading suppliers - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S. Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment. - Five-year test volume and sales projections. Market Segmentation Analysis - Five-year test volume and sales projections: - Infectious Diseases - Forensic Testing - Cancer - Paternity Testing/HLA Typing - Genetic Diseases - Others - A comprehensive analysis of the sequencing market by laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review - Comparison of the major molecular diagnosticanalyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom For more information visit http://www.researchandmarkets.com/research/kx...152019_u_s
SQNM: 2.39 (-0.01), MYGN: 20.75 (-0.01), A: 46.04 (+0.33), CPHD: 52.53 (+0.04), DHR: 77.45 (+0.73), HOLX: 38.53 (+0.29)
United States Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets 2014-2018
M2 - Fri Jul 10, 9:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2b5nf8/20142018_u_s) has announced the addition of the "2014-2018 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies" report to their offering. Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. This new five-country study contains 495 pages, 28 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. Report Highlights - Market shares of leading suppliers - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing by country and market segment. - Five-year test volume and sales projections by country. Market Segmentation Analysis Five-year test volume and sales projections: - Infectious Diseases Forensic Testing - Cancer Paternity Testing/HLA Typing - Genetic DiseasesOthers - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country. Product/Technology Review - Comparison of the major molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/2b...142018_u_s
LIFE: 3.29 (+0.07), MYGN: 20.75 (-0.01), A: 46.04 (+0.33), DHR: 77.45 (+0.73), SQNM: 2.39 (-0.01), CPHD: 52.53 (+0.04), HOLX: 38.53 (+0.29)
World Infectious Disease Molecular Diagnostics Market 2015-2019
M2 - Thu Jul 09, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c4c7sd/20152019_world) has announced the addition of the "2015-2019 World Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies" report to their offering. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. Worldwide Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment. - Five-year test volume and sales projections by country. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country. Product/Technology Review - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Grifols - Hologic/Gen-Probe Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/c4...2019_world
MYGN: 20.75 (-0.01), A: 46.04 (+0.33), DHR: 77.45 (+0.73), SQNM: 2.39 (-0.01), CPHD: 52.53 (+0.04), HOLX: 38.53 (+0.29)
United States Infectious Disease Molecular Diagnostics Market 2015-2019 - Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
M2 - Wed Jul 08, 6:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9pjgrg/20152019_us) has announced the addition of the "2015-2019 US Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies" report to their offering. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S. Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testingfor infectious diseases Market segment. - Five-year test volume and sales projections. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review - Comparison of leading infectious disease molecular diagnosticanalyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/9p...0152019_us
MYGN: 20.75 (-0.01), A: 46.04 (+0.33), CPHD: 52.53 (+0.04), DHR: 77.45 (+0.73), HOLX: 38.53 (+0.29)
World Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets 2015-2019 - Country Forecasts, Emerging Technologies, Competitive Strategies
M2 - Tue Jul 07, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cshv2m/20152019_world) has announced the addition of the "2015-2019 World Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies" report to their offering. This new seven-country study contains 570 pages, 42 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. Report Highlights - Market shares of leading suppliers - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Roche - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/cs...2019_world
MYGN: 20.75 (-0.01), A: 46.04 (+0.33), CPHD: 52.53 (+0.04), DHR: 77.45 (+0.73), HOLX: 38.53 (+0.29)
New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape
PR Newswire Europe - Thu Jul 02, 7:03AM CDT
Research and Markets(http://www.researchandmarkets.com/research/8mfjxh/2015_new [http://www.researchandmarkets.com/research/8mfjxh/2015_new]) has announced the addition of the "2015 New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape" [http://www.researchandmarkets.com/research/8mfjxh/2015_new] report to their offering.
ABT: 41.93 (+0.01), A: 46.04 (+0.33), DGX: 84.86 (+1.76), DHR: 77.45 (+0.73)
2015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape
PR Newswire Europe - Wed Jul 01, 10:46AM CDT
Research and Markets(http://www.researchandmarkets.com/research/34xqr7/2015_new [http://www.researchandmarkets.com/research/34xqr7/2015_new]) has announced the addition of the "2015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape" [http://www.researchandmarkets.com/research/34xqr7/2015_new] report to their offering.
ABT: 41.93 (+0.01), A: 46.04 (+0.33), DGX: 84.86 (+1.76), DHR: 77.45 (+0.73)
Global Endocrine Testing Market 2015-2019
M2 - Wed Jun 24, 5:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3tpnbl/global_endocrine) has announced the addition of the "Global Endocrine Testing Market 2015-2019" report to their offering. The global endocrine testing market to grow at a CAGR of 4.66% over the period 2014-2019. Endocrine testing system refers to a collection of tests that involve all the glands of the body and the hormones produced by those glands. The endocrine system together with nervous system regulates and controls many internal body functions. While the endocrine system uses chemical messengers called hormones, the nervous system uses nerve impulses as a means of control. The endocrine system plays a role in reproduction, growth and sexual development, responses to injury and stress, body energy levels, bone and muscle strength, and internal balance of the body. The global endocrine testing market is witnessing a shift from conventional (manual) to semi-automated and highly automated systems. Automation allows laboratories to increase productivity and efficiently handle higher test volumes with fewer people. It is also useful in cases of critical shortage of trained technicians. In addition, automated systems offer a level of precision that cannot be achieved consistently by manual methods. For instance, the adoption of AUF in endocrine testing is increasing. AUF involves preparation of a sample of therapeutic drugs (e.g. Dilantin) and hormones (e.g., testosterone) efficiently for various diagnostic procedures using an automated system. Thus, it can replace the existing manual centrifugation/dialysis preparation step. The current separation process involves dialysis, which takes about 18 hours, while with AUF technology, centrifugation can be done within 30 minutes. According to the report, the number of people aged 60 and over will reach 2 billion people by 2050. By 2030, more than 22% of the world's population will be over 65. The elderly are more susceptible to diseases such as diabetes, hypertension, musculoskeletal and cardiovascular diseases, chronic kidney diseases, cerebral strokes, and cancer. Hence, the need for early and reliable diagnosis will boost the growth of the global endocrine testing market. Further, the report states that limited detection and complexity of immunoassays will hinder the widespread adoption of endocrine testing devices and instruments. To calculate the market size, we consider the revenue generated from the sales of the products (instruments and reagents) used in the following endocrine testing technologies: Types of Diagnostic Technologies - Clinical chemistry technologies - Immunoassay technologies - Tandem mass spectrometry - Monoclonal and polyclonal antibodies - Sensor technologies - Others The report also provides information about the following endocrine tests: - FSH - TSH - hCG - DHEAS - Progesterone - Testosterone - Insulin - Prolactin - Cortisol - Estradiol - Luteinizing Hormone Key Vendors - Abbott Diagnostics - Diascorin - Roche Diagnostics - Siemens Healthcare - Thermo Fisher Scientific Other Prominent Vendor - AdnaGen - Alere - Allele Biotechnology - Axis-Shield - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - Diametra - Enzo Life Sciences - Fujirebio - ImmunoDX - Immunonodiagnostics System - InDevR - Innogenetics - Kyowa Medex - Merck Millipore - Meridian Bioscience - Meso Scale Discovery - NanoEnTek - Nova Century Scientific - Ortho-Clinical Diagnostics - Quidel - Randox - SDIX - Sysmex - Tecan - Tosoh Bioscience - Vital Diagnostics - ZEUS Scientific For more information visit http://www.researchandmarkets.com/research/3t..._endocrine
VIVO: 19.20 (+0.05), MRK: 62.70 (+0.76), DHR: 77.45 (+0.73)
The Global Syphilis Testing Market is Expected to Reach $3,650.3 Million by 2020, at a CAGR of 1.2%, from 2014 to 2020
M2 - Thu Jun 18, 9:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j4rm7z/global_syphilis) has announced the addition of the "Global Syphilis Testing Market (Types and Geography) - Global Industry Analysis, Country-Wise Market Size, Share, Growth, Company Profiles, Demand, Insights, Trends and Forecast, 2014 - 2020" report to their offering. LAMEA and Asia Pacific constitute the two largest regions for syphilis testing market and collectively accounted for about 4/5th of the global revenue in 2014. Higher adoption rates for technologically advanced screening tests methods, active measures from governments and private associations along with the growing awareness of syphilis infections, largely contributes to the growth of the market in these regions. Also, rising incidences of syphilis due to men having sex with men (MSM) and implementation of mandatory screening tests for all pregnant women would further foster the growth of syphilis testing market in these regions. Key findings of the study: - LAMEA will continue to lead the global market, closely followed by Asia Pacific, all through the analysis period - United states remains a major market in North America syphilis testing market through 2020 - Spain and Germany collectively accounts for about one fourth of the Europe syphilis testing market - China and India collectively accounts for about 89% share in the Asia Pacific syphilis testing market Companies Mentioned: - Abbott Laboratories - Affymetrix - Alere Inc. - Becton Dickinson And Company - BioMerieux - Cepheid Inc. - Danaher Corporation - DiaSorin - Hologic - Roche Diagnostics For more information visit http://www.researchandmarkets.com/research/j4...l_syphilis About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
ABT: 41.93 (+0.01), CPHD: 52.53 (+0.04), DHR: 77.45 (+0.73), ALR: 43.33 (+0.70), HOLX: 38.53 (+0.29)
2015 Strategies in the UK Drugs of Abuse Testing Market Report Explores Future Trends and Provides Forecasts
M2 - Wed Jun 10, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mccfc2/2015_strategies) has announced the addition of the "2015 Strategies in the UK Drugs of Abuse Testing Market" report to their offering. This new 260-page report provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP) and Propoxphene. During the next five years, the abused drug testing market will undergo significant transformation.These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. "2015 Strategies for the UK Drugs of Abuse Testing Market" is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. Companies Mentioned: - Abbott Laboratories - AdnaGen/Alere - Agilent Technologies - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - DiaSorin - Eiken - Fujirebio - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Quest Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/mc...strategies About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
ABT: 41.93 (+0.01), A: 46.04 (+0.33), DGX: 84.86 (+1.76), DHR: 77.45 (+0.73)
Strategies in the Global Immunoprotein Diagnostic Testing Market 2015 - Includes Stategic Profiles of Leading Suppliers
M2 - Thu Aug 13, 10:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rw5f5m/2015_strategies) has announced the addition of the "2015 Strategies in the Global Immunoprotein Diagnostic Testing Market" report to their offering. This new 297-page report contains 72 tables and provides analysis of the global immunoprotein diagnostic market, including: - emerging tests - technologies - instrumentation - sales forecasts by country - market shares - strategic profiles of leading suppliers Companies Mentioned: - Abbott Laboratories - AdnaGen - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - Dako - DiaSorin - Eiken - Fujirebio - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/rw...strategies About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
ABT: 41.93 (+0.01), DHR: 77.45 (+0.73)
2015-2019 Global Transfusion Diagnostic Testing Market: US, Europe, Japan--Strategic Profiles of Leading Suppliers, Country Volume and Sales Forecasts
PR Newswire Europe - Mon Aug 10, 11:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pdhqcr/20152019_global [http://www.researchandmarkets.com/research/pdhqcr/20152019_global]) has announced the addition of the "2015-2019 Global Transfusion Diagnostic Testing Market: US, Europe, Japan--Strategic Profiles of Leading Suppliers, Country Volume and Sales Forecasts" [http://www.researchandmarkets.com/research/pdhqcr/20152019_global] report to their offering.
DHR: 77.45 (+0.73)
2015-2019 Global Transfusion Diagnostic Testing Market - Presents Analyses of Leading Current and Emerging Suppliers
M2 - Mon Aug 10, 9:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z4c75f/20152019_global) has announced the addition of the "2015-2019 Global Transfusion Diagnostic Testing Market: US, Europe, Japan--Strategic Profiles of Leading Suppliers, Country Volume and Sales Forecasts" report to their offering. 2015-2019 Global Transfusion Diagnostic Testing Market: US, Europe, Japan--Strategic Profiles of Leading Suppliers, Country Volume and Sales Forecasts This report provides a worldwide overview of the Transfusion Diagnostic Testing market, including estimates of facilities performing blood banking tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country. The report also presents analyses of leading current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Table of Contents 1. Worldwide Business Environment 2. Worldwide Market Structure 3. Worldwide Market Size and Growth 4. Competitive Assessments: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Gen-Probe - Grifols - Immucor - Ortho-Clinical Diagnostics - Proteome Sciences - Roche - Siemens - Tecan List of Tables Worldwide, All Market Segments, Facilities Performing Blood Bank Tests By Country Worldwide, All Market Segments, Blood Typing and Grouping Test Volume Forecast By Country Worldwide, All Market Segments, Infectious Disease Screening Test Volume Forecast By Country Worldwide, All Market Segments, Blood Typing and Grouping Reagent Market Forecast By Country Worldwide, All Market Segments, Infectious Disease Screening Reagent Market Forecast By Country For more information visit http://www.researchandmarkets.com/research/z4...019_global
DHR: 77.45 (+0.73)
2015 New Frontiers in US Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape
M2 - Thu Aug 06, 9:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4h3942/2015_new) has announced the addition of the "2015 New Frontiers in US Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape" report to their offering. 2015 New Frontiers in US Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape is a new study of the major business opportunities emerging in the US clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the US market; provides estimates of the specimen, test and sales volumes, as well as major suppliers' sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years. The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables. The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators. Companies Mentioned - Abbott Laboratories - AdnaGen/Alere - Agilent Technologies - Bayer Healthcare - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - DiaSorin - Eiken - Fujirebio - Grifols - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Quest Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/4h3942/2015_new
ABT: 41.93 (+0.01), A: 46.04 (+0.33), DGX: 84.86 (+1.76), DHR: 77.45 (+0.73)
2015 US Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test
M2 - Thu Aug 06, 9:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jf2lnb/2015_us_sales_and) has announced the addition of the "2015 US Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test" report to their offering. This unique report provides US sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher List of Tables - U.S.A., Major Suppliers of Blood Typing and Grouping Reagents Sales and Market Shares - U.S.A., HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier - U.S.A., Hepatitis Blood Screening Market, Reagents Sales by Major Supplier - U.S.A., Hepatitis C Blood Screening Market, Reagent Sales by Major Supplier - U.S.A., HIV/Hepatitis C NAT Market, Reagent Sales by Major Supplier - U.S.A., West Nile Virus NAT Market, Reagent Sales by Major Supplier - U.S.A., CMV Blood Screening Market, Reagent Sales by Major Supplier - U.S.A., Syphilis Blood Screening Market, Reagent Sales by Major Supplier Contains 87 pages and 8 tables For more information visit http://www.researchandmarkets.com/research/jf..._sales_and
DHR: 77.45 (+0.73), HOLX: 38.53 (+0.29)
Global Infectious Disease Molecular Diagnostics Market 2015: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape
M2 - Wed Jul 29, 6:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kkvb5t/2015_global) has announced the addition of the "2015 Global Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape" report to their offering. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry.The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. This new seven-country study contains 775 pages, 73 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. Worldwide Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment. - Five-year test volume and sales projections by country. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country. Product/Technology Review - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Pharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forenciscs/LabCorp - DecodeGenetics - Diadexus - Eiken - Elitech Group - Enzo - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/kk...015_global
MYGN: 20.75 (-0.01), A: 46.04 (+0.33), CPHD: 52.53 (+0.04), DHR: 77.45 (+0.73), HOLX: 38.53 (+0.29)
US Nucleic Acid Testing/NAT Market 2015-2019: Sales and Market Shares of Major Suppliers
M2 - Mon Jul 20, 9:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/brtn3w/20152019_us) has announced the addition of the "2015-2019 US Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom For more information visit http://www.researchandmarkets.com/research/br...0152019_us
SQNM: 2.39 (-0.01), MYGN: 20.75 (-0.01), A: 46.04 (+0.33), CPHD: 52.53 (+0.04), DHR: 77.45 (+0.73), HOLX: 38.53 (+0.29)
US Molecular Diagnostics Market 2015-2019 - Sales and Market Shares of Major Suppliers
M2 - Mon Jul 20, 9:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9x3trk/20152019_us) has announced the addition of the "2015-2019 US Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Eiken - Elitech Group - Enzo - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/9x...0152019_us
SQNM: 2.39 (-0.01), MYGN: 20.75 (-0.01), A: 46.04 (+0.33), CPHD: 52.53 (+0.04), DHR: 77.45 (+0.73), HOLX: 38.53 (+0.29)
2015-2019 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets
M2 - Fri Jul 10, 10:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kx789r/20152019_u_s) has announced the addition of the "2015-2019 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies" report to their offering. Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. Report Highlights - Market shares of leading suppliers - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S. Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment. - Five-year test volume and sales projections. Market Segmentation Analysis - Five-year test volume and sales projections: - Infectious Diseases - Forensic Testing - Cancer - Paternity Testing/HLA Typing - Genetic Diseases - Others - A comprehensive analysis of the sequencing market by laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review - Comparison of the major molecular diagnosticanalyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom For more information visit http://www.researchandmarkets.com/research/kx...152019_u_s
SQNM: 2.39 (-0.01), MYGN: 20.75 (-0.01), A: 46.04 (+0.33), CPHD: 52.53 (+0.04), DHR: 77.45 (+0.73), HOLX: 38.53 (+0.29)
United States Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets 2014-2018
M2 - Fri Jul 10, 9:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2b5nf8/20142018_u_s) has announced the addition of the "2014-2018 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies" report to their offering. Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. This new five-country study contains 495 pages, 28 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. Report Highlights - Market shares of leading suppliers - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing by country and market segment. - Five-year test volume and sales projections by country. Market Segmentation Analysis Five-year test volume and sales projections: - Infectious Diseases Forensic Testing - Cancer Paternity Testing/HLA Typing - Genetic DiseasesOthers - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country. Product/Technology Review - Comparison of the major molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/2b...142018_u_s
LIFE: 3.29 (+0.07), MYGN: 20.75 (-0.01), A: 46.04 (+0.33), DHR: 77.45 (+0.73), SQNM: 2.39 (-0.01), CPHD: 52.53 (+0.04), HOLX: 38.53 (+0.29)
World Infectious Disease Molecular Diagnostics Market 2015-2019
M2 - Thu Jul 09, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c4c7sd/20152019_world) has announced the addition of the "2015-2019 World Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies" report to their offering. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. Worldwide Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment. - Five-year test volume and sales projections by country. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country. Product/Technology Review - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Grifols - Hologic/Gen-Probe Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/c4...2019_world
MYGN: 20.75 (-0.01), A: 46.04 (+0.33), DHR: 77.45 (+0.73), SQNM: 2.39 (-0.01), CPHD: 52.53 (+0.04), HOLX: 38.53 (+0.29)
United States Infectious Disease Molecular Diagnostics Market 2015-2019 - Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
M2 - Wed Jul 08, 6:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9pjgrg/20152019_us) has announced the addition of the "2015-2019 US Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies" report to their offering. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S. Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testingfor infectious diseases Market segment. - Five-year test volume and sales projections. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review - Comparison of leading infectious disease molecular diagnosticanalyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/9p...0152019_us
MYGN: 20.75 (-0.01), A: 46.04 (+0.33), CPHD: 52.53 (+0.04), DHR: 77.45 (+0.73), HOLX: 38.53 (+0.29)
World Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets 2015-2019 - Country Forecasts, Emerging Technologies, Competitive Strategies
M2 - Tue Jul 07, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cshv2m/20152019_world) has announced the addition of the "2015-2019 World Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies" report to their offering. This new seven-country study contains 570 pages, 42 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. Report Highlights - Market shares of leading suppliers - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Roche - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/cs...2019_world
MYGN: 20.75 (-0.01), A: 46.04 (+0.33), CPHD: 52.53 (+0.04), DHR: 77.45 (+0.73), HOLX: 38.53 (+0.29)
New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape
PR Newswire Europe - Thu Jul 02, 7:03AM CDT
Research and Markets(http://www.researchandmarkets.com/research/8mfjxh/2015_new [http://www.researchandmarkets.com/research/8mfjxh/2015_new]) has announced the addition of the "2015 New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape" [http://www.researchandmarkets.com/research/8mfjxh/2015_new] report to their offering.
ABT: 41.93 (+0.01), A: 46.04 (+0.33), DGX: 84.86 (+1.76), DHR: 77.45 (+0.73)
2015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape
PR Newswire Europe - Wed Jul 01, 10:46AM CDT
Research and Markets(http://www.researchandmarkets.com/research/34xqr7/2015_new [http://www.researchandmarkets.com/research/34xqr7/2015_new]) has announced the addition of the "2015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape" [http://www.researchandmarkets.com/research/34xqr7/2015_new] report to their offering.
ABT: 41.93 (+0.01), A: 46.04 (+0.33), DGX: 84.86 (+1.76), DHR: 77.45 (+0.73)
Global Endocrine Testing Market 2015-2019
M2 - Wed Jun 24, 5:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3tpnbl/global_endocrine) has announced the addition of the "Global Endocrine Testing Market 2015-2019" report to their offering. The global endocrine testing market to grow at a CAGR of 4.66% over the period 2014-2019. Endocrine testing system refers to a collection of tests that involve all the glands of the body and the hormones produced by those glands. The endocrine system together with nervous system regulates and controls many internal body functions. While the endocrine system uses chemical messengers called hormones, the nervous system uses nerve impulses as a means of control. The endocrine system plays a role in reproduction, growth and sexual development, responses to injury and stress, body energy levels, bone and muscle strength, and internal balance of the body. The global endocrine testing market is witnessing a shift from conventional (manual) to semi-automated and highly automated systems. Automation allows laboratories to increase productivity and efficiently handle higher test volumes with fewer people. It is also useful in cases of critical shortage of trained technicians. In addition, automated systems offer a level of precision that cannot be achieved consistently by manual methods. For instance, the adoption of AUF in endocrine testing is increasing. AUF involves preparation of a sample of therapeutic drugs (e.g. Dilantin) and hormones (e.g., testosterone) efficiently for various diagnostic procedures using an automated system. Thus, it can replace the existing manual centrifugation/dialysis preparation step. The current separation process involves dialysis, which takes about 18 hours, while with AUF technology, centrifugation can be done within 30 minutes. According to the report, the number of people aged 60 and over will reach 2 billion people by 2050. By 2030, more than 22% of the world's population will be over 65. The elderly are more susceptible to diseases such as diabetes, hypertension, musculoskeletal and cardiovascular diseases, chronic kidney diseases, cerebral strokes, and cancer. Hence, the need for early and reliable diagnosis will boost the growth of the global endocrine testing market. Further, the report states that limited detection and complexity of immunoassays will hinder the widespread adoption of endocrine testing devices and instruments. To calculate the market size, we consider the revenue generated from the sales of the products (instruments and reagents) used in the following endocrine testing technologies: Types of Diagnostic Technologies - Clinical chemistry technologies - Immunoassay technologies - Tandem mass spectrometry - Monoclonal and polyclonal antibodies - Sensor technologies - Others The report also provides information about the following endocrine tests: - FSH - TSH - hCG - DHEAS - Progesterone - Testosterone - Insulin - Prolactin - Cortisol - Estradiol - Luteinizing Hormone Key Vendors - Abbott Diagnostics - Diascorin - Roche Diagnostics - Siemens Healthcare - Thermo Fisher Scientific Other Prominent Vendor - AdnaGen - Alere - Allele Biotechnology - Axis-Shield - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - Diametra - Enzo Life Sciences - Fujirebio - ImmunoDX - Immunonodiagnostics System - InDevR - Innogenetics - Kyowa Medex - Merck Millipore - Meridian Bioscience - Meso Scale Discovery - NanoEnTek - Nova Century Scientific - Ortho-Clinical Diagnostics - Quidel - Randox - SDIX - Sysmex - Tecan - Tosoh Bioscience - Vital Diagnostics - ZEUS Scientific For more information visit http://www.researchandmarkets.com/research/3t..._endocrine
VIVO: 19.20 (+0.05), MRK: 62.70 (+0.76), DHR: 77.45 (+0.73)
The Global Syphilis Testing Market is Expected to Reach $3,650.3 Million by 2020, at a CAGR of 1.2%, from 2014 to 2020
M2 - Thu Jun 18, 9:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j4rm7z/global_syphilis) has announced the addition of the "Global Syphilis Testing Market (Types and Geography) - Global Industry Analysis, Country-Wise Market Size, Share, Growth, Company Profiles, Demand, Insights, Trends and Forecast, 2014 - 2020" report to their offering. LAMEA and Asia Pacific constitute the two largest regions for syphilis testing market and collectively accounted for about 4/5th of the global revenue in 2014. Higher adoption rates for technologically advanced screening tests methods, active measures from governments and private associations along with the growing awareness of syphilis infections, largely contributes to the growth of the market in these regions. Also, rising incidences of syphilis due to men having sex with men (MSM) and implementation of mandatory screening tests for all pregnant women would further foster the growth of syphilis testing market in these regions. Key findings of the study: - LAMEA will continue to lead the global market, closely followed by Asia Pacific, all through the analysis period - United states remains a major market in North America syphilis testing market through 2020 - Spain and Germany collectively accounts for about one fourth of the Europe syphilis testing market - China and India collectively accounts for about 89% share in the Asia Pacific syphilis testing market Companies Mentioned: - Abbott Laboratories - Affymetrix - Alere Inc. - Becton Dickinson And Company - BioMerieux - Cepheid Inc. - Danaher Corporation - DiaSorin - Hologic - Roche Diagnostics For more information visit http://www.researchandmarkets.com/research/j4...l_syphilis About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
ABT: 41.93 (+0.01), CPHD: 52.53 (+0.04), DHR: 77.45 (+0.73), ALR: 43.33 (+0.70), HOLX: 38.53 (+0.29)
2015 Strategies in the UK Drugs of Abuse Testing Market Report Explores Future Trends and Provides Forecasts
M2 - Wed Jun 10, 10:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mccfc2/2015_strategies) has announced the addition of the "2015 Strategies in the UK Drugs of Abuse Testing Market" report to their offering. This new 260-page report provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP) and Propoxphene. During the next five years, the abused drug testing market will undergo significant transformation.These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. "2015 Strategies for the UK Drugs of Abuse Testing Market" is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. Companies Mentioned: - Abbott Laboratories - AdnaGen/Alere - Agilent Technologies - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - DiaSorin - Eiken - Fujirebio - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Quest Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/mc...strategies About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
ABT: 41.93 (+0.01), A: 46.04 (+0.33), DGX: 84.86 (+1.76), DHR: 77.45 (+0.73)
(0)
(0)Scroll down for more posts ▼